Medicinal cannabis: minimising harm in a changing landscape
Regulators have raised the alarm about soaring cannabis scripts, issuing new guidance in a bid to minimise patient harm and curb inappropriate prescribing. Kate Cowling reports on what’s happened—and what …
New sunscreens pulled over SPF fears
More sunscreen brands have hit pause on sales following Choice’s damning SPF findings earlier this year, as questions are raised about how many share the same base formulations Several sunscreens …
Priceline’s lessons from Bunnings and Kmart
Wesfarmers Health is adopting similar strategies to its retail giant siblings to grow its margins and market share Private label is set to become a bigger part of the Priceline …
RHC pharmacy revenue up amid broader headwinds
Hospital and community pharmacy revenue increased 8% in an otherwise tough year for the hospital operator Australia’s largest hospital operator Ramsay Health Care posted a 97% drop in net profit …
Priceline sales boost Wesfarmers Health revenue
The retail conglomerate says consumer demand lifted the health division’s earnings, but wholesale challenges continue Priceline owner Wesfarmers Health increased its revenue by 5.5% in the past financial year, with …
CWH contract loss bites into EBOS’ revenue
The New Zealand-based wholesaler posted a drop in revenue and profit after its CWH supply contract ended, but says TWC and high value medicines have delivered for the business EBOS’ …
Chemist Warehouse’s $10bn milestone
The first official look at combined Sigma and Chemist Warehouse earnings shows the retail giant has grown further, with greater expansion on the cards Wholesaler Sigma Healthcare has reported an …
‘We are deeply sorry’: Sunscreen pulled, brand admits SPF irregularity
A popular sunscreen brand says independent testing showed a product ‘demonstrated significant, and candidly, atypical variability’ in SPF data, prompting its withdrawal, as TGA admits its testing takes time Australian …
Pharmas shrug off tariff threats
Two ASX-listed companies have responded to looming US-imposed pharmaceutical tariffs, with one pricing in an impact on hospital products Sleep apnoea company Fisher and Paykel Healthcare says it’s expecting a …
Battle of the banners: Who has grown the most in two years?
Australia’s biggest banner groups have been on a mergers and acquisitions spree in the past couple of years, as the industry adjusts following Covid and in the face of increasing …
‘Administrative oversight’: Jack Gance’s Sigma holding slightly understated
The ASX-listed company has corrected records to show the CWH co-founder had marginally more shares in Sigma than originally stated at the time of the historic merger vote Sigma Healthcare …
‘This is a monumental shift’
The pharmacy landscape is changing from a medicine-supply model to a primary care health hub model, an early pharmacist prescriber has told a national conference Pharmacists working at full scope …